The landscape of diabetes care is changing with the arrival of skin-applied GLP-1 therapy. These innovative devices offer a potentially less invasive alternative to injections for individuals managing type 2 diabetes . These patches deliver a GLP-1 agonist directly through the dermis , circumventing the need for frequent injections and perhaps i⦠Read More